Tim Sandle explores the main factors that influence particle accumulation in pharmaceutical cleanrooms, advising how best to control risks and minimise operator contamination.
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
During this webinar industry experts will share practical insight and considerations for modernising pharmaceutical downstream workflows.
EPR’s 2026 cell and gene therapy report covers the key developments in manufacturing, regulation, drug delivery, process development and beyond.
New appointments will drive manufacturing efficiency in Sandoz’s generics business and merger and acquisition activities globally.
Agreement with Dizal Pharmaceutical gives the pharmaceutical giant access to the only approved oral targeted therapy for EGFR exon 20 insertion NSCLC in both the US and China.
Genetically modified Bifidobacterium could enhance patient response to immune checkpoint inhibitors, new clinical data suggests.
Proposal aims to modernise registration for distributed drug manufacturers, strengthening real-time transparency across the pharmaceutical supply chain.
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
Optimal excipient choice can enhance both the therapeutic impact and patient-centricity of oral and parenteral formulations.
Join this webinar to discover how reporter assay-based MAT can help laboratories accelerate pyrogen testing, simplify workflows and support the transition to animal-free testing while maintaining confidence in results.
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.